There is a plan by the EU to tighten the exports of Covid vaccines produced in the bloc.
This development has occurred while there is a row with AstraZeneca over a cut in planned supplies.
While highlighting its challenges last week, AstraZeneca told the EU it was falling behind on its supply target because of production problems.
On distribution, Pfizer-BioNTech has disclosed that supplies of its vaccine will be lower, slowing down the EU’s vaccination drive.
Bearing in mind the need for the vaccine globally, as nations seek to stem high infection rates; its supply has become a critical issue.
At the moment a particular brand, Pfizer’s Belgian plant supplies the UK.
Meanwhile, the AstraZeneca row could affect supplies to the UK of the Pfizer-BioNTech vaccine, which has been developed by the US and Germany.
In reaction to these developments, the EU has made comments. The UK’s Minister for Covid Vaccine Deployment Nadhim Zahawi also disclosed on Tuesday that supplies were “tight”
Speaking further, he said, “I’m confident that [AstraZeneca and Pfizer-BioNTech] will both deliver for us the quantities that we need to meet our mid-February target and of course beyond.”
EU Health Commissioner Stella Kyriakides had earlier said the 27-member EU bloc would “take any action required to protect its citizens.”